Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CREATIVE REALITIES, INC. | 6,352 | reported | 01 Oct 2019 | tx 2+6,352 |
| Apellis Pharmaceuticals, Inc. | 0 | reported | 14 May 2026 | tx 171+872,750−1,744,829 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 384,989 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 250,000 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 11,950 | — | |
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 150,000 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,062 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5,744 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7,961 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,544 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 17,580 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 121,894 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14,684 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27,600 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11,199 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8,554 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7,441 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27,600 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5,748 | — | deriv |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7,961 | 0.00 USD | |
| 01 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14,684 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 6,267 | 0.00 USD | |
| 01 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 11,199 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3,341 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5,748 | 59.86 USD | deriv |
| 17 Nov 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 1,250 | 2.67 USD | |
| 17 Nov 2023 | SALE | Apellis Pharmaceuticals, Inc. | 1,250 | 47.74 USD |